FormWeb • alosetron

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

alosetron

alosetron

Formulary Miscellaneous Programs

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Lotronex	TABLET, ORAL	0.5 mg, 1 mg

Comments:

Lotronex medication guide

LOTRONEX is indicated only for women with severe diarrhea-predominant irritable bowel syndrome who have failed conventional therapy.

Patient may use his/her home supply.

Reviewed: June 22, 2010

Last updated: Nov. 20, 2025

Black Box Warning: Serious GI Reactions; indication; discontinuation
Formulary, Not Routinely Stocked: Lotronex: 0.5 mg tablet, 1 mg tablet

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.